Different activation signals induce distinct mast cell degranulation strategies

Journal of Clinical Investigation

Volumn 126, Issue 10, 2016, Pages 3981-3998

  Gaudenzio, Nicolas ^a   Sibilano, Riccardo ^a   Marichal, Thomas ^b   Starkl, Philipp ^a   Reber, Laurent L ^a   Cenac, Nicolas ^c   McNeil, Benjamin D ^d   Dong, Xinzhong ^d   Hernandez, Joseph D ^a   Sagi Eisenberg, Ronit ^e   Hammel, Ilan ^e   Roers, Axel ^f   Valitutti, Salvatore ^c   Tsai, Mindy ^a   Espinosa, Eric ^c   Galli, Stephen J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c INSERM   (France)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e TEL AVIV UNIVERSITY   (Israel)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; ENDOTHELIN 1; IMMUNOGLOBULIN E; MEMBRANE PROTEIN; SNAP23 PROTEIN; SUBSTANCE P; SYNTAXIN 4; UNCLASSIFIED DRUG; CHEMOKINE; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CELL ACTIVATION; CELL COMMUNICATION; CELL GRANULE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SECRETION; ANIMAL; CALCIUM SIGNALING; CELL CULTURE; DEGRANULATION; MAST CELL; METABOLISM; PHYSIOLOGY; SECRETION (PROCESS);

ANIMALS; CALCIUM SIGNALING; CELL DEGRANULATION; CELLS, CULTURED; CHEMOKINES; CYTOPLASMIC GRANULES; HUMANS; IMMUNOGLOBULIN E; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAST CELLS; MICE; SUBSTANCE P;

EID: 84991619659     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI85538     Document Type: Article

References (71)

1. Burgoyne RD, Morgan A. Secretory granule exocytosis. Physiol Rev. 2003;83(2):581-632.
2. Metz M, et al. Mast cells can enhance resistance to snake and honeybee venoms. Science. 2006;313(5786):526-530.
3. Schneider LA, Schlenner SM, Feyerabend TB, Wunderlin M, Rodewald HR. Molecular mechanism of mast cell mediated innate defense against endothelin and snake venom sarafotoxin. J Exp Med. 2007;204(11):2629-2639.
4. Marichal T, et al. A beneficial role for immunoglobulin E in host defense against honeybee venom. Immunity. 2013;39(5):963-975.
5. Abraham SN, St John AL. Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol. 2010;10(6):440-452.
6. Stone KD, Prussin C, Metcalfe DD. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol. 2010;125(2 suppl 2):S73-S80.
7. Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med. 2012;18(5):693-704.
8. Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol. 2005;6(2):135-142.
9. MacGlashan DW. Self-termination/anergic mechanisms in human basophils and mast cells. Int Arch Allergy Immunol. 2009;150(2):109-121.
10. Azouz NP, Hammel I, Sagi-Eisenberg R. Characterization of mast cell secretory granules and their cell biology. DNA Cell Biol. 2014;33(10):647-651.
11. Turner H, Kinet JP. Signalling through the high-affinity IgE receptor Fc epsilonRI. Nature. 1999;402(6760 suppl):B24-B30.
12. Gilfillan AM, Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat Rev Immunol. 2006;6(3):218-230.
13. Kalesnikoff J, Galli SJ. New developments in mast cell biology. Nat Immunol. 2008;9(11):1215-1223.
14. Galli SJ, Borregaard N, Wynn TA. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol. 2011;12(11):1035-1044.
15. Sibilano R, Frossi B, Pucillo CE. Mast cell activation: a complex interplay of positive and negative signaling pathways. Eur J Immunol. 2014;44(9):2558-2566.
16. Wernersson S, Pejler G. Mast cell secretory granules: armed for battle. Nat Rev Immunol. 2014;14(7):478-494.
17. Maurer M, et al. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature. 2004;432(7016):512-516.
18. Wang H, Wang HS, Liu ZP. Agents that induce pseudo-allergic reaction. Drug Discov Ther. 2011;5(5):211-219.
19. Schafer B, et al. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice. J Allergy Clin Immunol. 2013;131(2):541-548.e1.
20. Yano H, Wershil BK, Arizono N, Galli SJ. Substance P-induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell dependent. J Clin Invest. 1989;84(4):1276-1286.
21. Verschraegen CF, et al. Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer. Gynecol Oncol. 2003;90(3):552-559.
22. Lumry WR, et al. Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial. Ann Allergy Asthma Immunol. 2011;107(6):529-537.
23. Nishida K, et al. FcϵRI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane. J Cell Biol. 2005;170(1):115-126.
24. Tiwari N, et al. VAMP-8 segregates mast cell-preformed mediator exocytosis from cytokine trafficking pathways. Blood. 2008;111(7):3665-3674.
25. Kunder CA, et al. Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J Exp Med. 2009;206(11):2455-2467.
26. Cohen R, Corwith K, Holowka D, Baird B. Spatiotemporal resolution of mast cell granule exocytosis reveals correlation with Ca2+ wave initiation. J Cell Sci. 2012;125(pt 12):2986-2994.
27. Azouz NP, et al. Rab5 is a novel regulator of mast cell secretory granules: impact on size, cargo, and exocytosis. J Immunol. 2014;192(9):4043-4053.
28. Brochetta C, et al. Munc18-2 and syntaxin 3 control distinct essential steps in mast cell degranulation. J Immunol. 2014;192(1):41-51.
29. Vincent L, et al. Mast cell activation contributes to sickle cell pathobiology and pain in mice. Blood. 2013;122(11):1853-1862.
30. Fujisawa D, et al. Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria. J Allergy Clin Immunol. 2014;134(3):622-633.e9.
31. Tatemoto K, et al. Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors. Biochem Biophys Res Commun. 2006;349(4):1322-1328.
32. McNeil BD, et al. Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature. 2015;519(7542):237-241.
33. Gaudenzio N, Laurent C, Valitutti S, Espinosa E. Human mast cells drive memory CD4+ T cells toward an inflammatory IL-22+ phenotype. J Allergy Clin Immunol. 2013;131(5):1400-1407.e11.
34. Joulia R, et al. Mast cells form antibody-dependent degranulatory synapse for dedicated secretion and defence. Nat Commun. 2015;6:6174.
35. Dvorak AM. Human mast cells. Adv Anat Embryol Cell Biol. 1989;114:1-107.
36. Subramanian H, Kashem SW, Collington SJ, Qu H, Lambris JD, Ali H. PMX-53 as a dual CD88 antagonist and an agonist for Mas-related gene 2 (MrgX2) in human mast cells. Mol Pharmacol. 2011;79(6):1005-1013.
37. Johnson AR, Moran NC. Selective release of histamine from rat mast cells by compound 48-80 and antigen. Am J Physiol. 1969;216(3):453-459.
38. Dvorak AM, et al. Immunoglobulin E-mediated degranulation of isolated human lung mast cells. Lab Invest. 1985;53(1):45-56.
39. Dvorak AM, Massey W, Warner J, Kissell S, Kagey-Sobotka A, Lichtenstein LM. IgE-mediated anaphylactic degranulation of isolated human skin mast cells. Blood. 1991;77(3):569-578.
40. Williams RM, Webb WW. Single granule pH cycling in antigen-induced mast cell secretion. J Cell Sci. 2000;113(pt 21):3839-3850.
41. Wollman R, Meyer T. Coordinated oscillations in cortical actin and Ca2+ correlate with cycles of vesicle secretion. Nat Cell Biol. 2012;14(12):1261-1269.
42. Malbec O, et al. Peritoneal cell-derived mast cells: an in vitro model of mature serosal-type mouse mast cells. J Immunol. 2007;178(10):6465-6475.
43. Gaudenzio N, Espagnolle N, Mars LT, Liblau R, Valitutti S, Espinosa E. Cell-cell cooperation at the T helper cell/mast cell immunological synapse. Blood. 2009;114(24):4979-4988.
44. Lorentz A, Baumann A, Vitte J, Blank U. The SNARE Machinery in Mast Cell Secretion. Front Immunol. 2012;3:143.
45. Guo Z, Turner C, Castle D. Relocation of the t-SNARE SNAP-23 from lamellipodia-like cell surface projections regulates compound exocytosis in mast cells. Cell. 1998;94(4):537-548.
46. Paumet F, et al. Soluble NSF attachment protein receptors (SNAREs) in RBL-2H3 mast cells: functional role of syntaxin 4 in exocytosis and identification of a vesicle-associated membrane protein 8-containing secretory compartment. J Immunol. 2000;164(11):5850-5857.
47. Suzuki K, Verma IM. Phosphorylation of SNAP-23 by IκB kinase 2 regulates mast cell degranulation. Cell. 2008;134(3):485-495.
48. Peschke K, et al. IκB kinase 2 is essential for IgE-induced mast cell de novo cytokine production but not for degranulation. Cell Rep. 2014;8(5):1300-1307.
49. Burke JR, et al. BMS-345541 is a highly selective inhibitor of IκB kinase that binds at an allosteric site of the enzyme and blocks NF-κB-dependent transcription in mice. J Biol Chem. 2003;278(3):1450-1456.
50. MacMaster JF, et al. An inhibitor of IκB kinase, BMS-345541, blocks endothelial cell adhesion molecule expression and reduces the severity of dextran sulfate sodium-induced colitis in mice. Inflamm Res. 2003;52(12):508-511.
51. McIntyre KW, et al. A highly selective inhibitor of IκB kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice. Arthritis Rheum. 2003;48(9):2652-2659.
52. Townsend RM, et al. A highly selective inhibitor of IκB kinase, BMS-345541, augments graft survival mediated by suboptimal immunosuppression in a murine model of cardiac graft rejection. Transplantation. 2004;77(7):1090-1094.
53. Karim ZA, et al. IκB kinase phosphorylation of SNAP-23 controls platelet secretion. Blood. 2013;121(22):4567-4574.
54. Hammel I, Lagunoff D, Galli SJ. Regulation of secretory granule size by the precise generation and fusion of unit granules. J Cell Mol Med. 2010;14(7):1904-1916.
55. Scholten J, et al. Mast cell-specific Cre/loxP-mediated recombination in vivo. Transgenic Res. 2008;17(2):307-315.
56. Dudeck A, et al. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity. 2011;34(6):973-984.
57. Riley JF. Histamine in tissue mast cells. Science. 1953;118(3064):332.
58. Heltianu C, Simionescu M, Simionescu N. Histamine receptors of the microvascular endothelium revealed in situ with a histamine-ferritin conjugate: characteristic high-affinity binding sites in venules. J Cell Biol. 1982;93(2):357-364.
59. McLeod RL, Mingo GG, Kreutner W, Hey JA. Effect of combined histamine H1 and H3 receptor blockade on cutaneous microvascular permeability elicited by compound 48/80. Life Sci. 2005;76(16):1787-1794.
60. Kunder CA, St John AL, Abraham SN. Mast cell modulation of the vascular and lymphatic endothelium. Blood. 2011;118(20):5383-5393.
61. Wershil BK, Mekori YA, Murakami T, Galli SJ. 125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells. J Immunol. 1987;139(8):2605-2614.
62. Grady EF, et al. Substance P mediates inflammatory oedema in acute pancreatitis via activation of the neurokinin-1 receptor in rats and mice. Br J Pharmacol. 2000;130(3):505-512.
63. Egawa G, Nakamizo S, Natsuaki Y, Doi H, Miyachi Y, Kabashima K. Intravital analysis of vascular permeability in mice using two-photon microscopy. Sci Rep. 2013;3:1932.
64. Akahoshi M, et al. Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice. J Clin Invest. 2011;121(10):4180-4191.
65. Gibbs BF, Wierecky J, Welker P, Henz BM, Wolff HH, Grabbe J. Human skin mast cells rapidly release preformed and newly generated TNF-alpha and IL-8 following stimulation with anti-IgE and other secretagogues. Exp Dermatol. 2001;10(5):312-320.
66. Kulka M, Sheen CH, Tancowny BP, Grammer LC, Schleimer RP. Neuropeptides activate human mast cell degranulation and chemokine production. Immunology. 2008;123(3):398-410.
67. Jensen BM, Frandsen PM, Raaby EM, Schiotz PO, Skov PS, Poulsen LK. Molecular and stimulus-response profiles illustrate heterogeneity between peripheral and cord blood-derived human mast cells. J Leukoc Biol. 2014;95(6):893-901.
68. Suzuki R, et al. Molecular editing of cellular responses by the high-affinity receptor for IgE. Science. 2014;343(6174):1021-1025.
69. Maurer M, Church MK. Inflammatory skin responses induced by icatibant injection are mast cell mediated and attenuated by H(1)-antihistamines. Exp Dermatol. 2012;21(2):154-155.
70. Bochner BS, et al. Interleukin-1 is released at sites of human cutaneous allergic reactions. J Allergy Clin Immunol. 1990;86(6 pt 1):830-839.
71. St John AL, Chan CY, Staats HF, Leong KW, Abraham SN. Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes. Nat Mater. 2012;11(3):250-257.